Deficiency of Nuclear Factor-κB c-Rel Accelerates the Development of Autoimmune Diabetes in NOD Mice by Ramakrishnan, Parameswaran et al.
Parameswaran Ramakrishnan,1 Mary A. Yui,2 Jeffrey A. Tomalka,1
Devdoot Majumdar,2 Reshmi Parameswaran,1 and David Baltimore2
Deﬁciency of Nuclear Factor-kB c-Rel
Accelerates the Development of
Autoimmune Diabetes in NOD Mice
Diabetes 2016;65:2367–2379 | DOI: 10.2337/db15-1607
The nuclear factor-kB protein c-Rel plays a critical role
in controlling autoimmunity. c-Rel–deﬁcient mice are
resistant to streptozotocin-induced diabetes, a drug-
induced model of autoimmune diabetes. We generated
c-Rel–deﬁcient NOD mice to examine the role of c-Rel
in the development of spontaneous autoimmune diabe-
tes. We found that both CD4+ and CD8+ T cells from
c-Rel–deﬁcient NOD mice showed signiﬁcantly de-
creased T-cell receptor–induced IL-2, IFN-g, and GM-
CSF expression. Despite compromised T-cell function,
c-Rel deﬁciency dramatically accelerated insulitis and
hyperglycemia in NOD mice along with a substantial
reduction in T-regulatory (Treg) cell numbers. Supple-
mentation of isogenic c-Rel–competent Treg cells from
prediabetic NOD mice reversed the accelerated dia-
betes development in c-Rel–deﬁcient NOD mice. The
results suggest that c-Rel–dependent Treg cell function
is critical in suppressing early-onset autoimmune diabe-
togenesis in NOD mice. This study provides a novel nat-
ural system to study autoimmune diabetes pathogenesis
and reveals a previously unknown c-Rel–dependent mech-
anistic difference between chemically induced and spon-
taneous diabetogenesis. The study also reveals a unique
protective role of c-Rel in autoimmune diabetes, which is
distinct from other T-cell–dependent autoimmune dis-
eases such as arthritis and experimental autoimmune en-
cephalomyelitis, where c-Rel promotes autoimmunity.
Type 1 diabetes is an autoimmune disorder in which the
immune system is self-reactive and destroys the insulin-
producing b-cells in the pancreas (1,2). It leads to hyper-
glycemia and severe secondary complications from chronic
inﬂammation that lead to blindness, renal failure, nerve
damage, and cardiovascular dysfunction (3). Although
high blood glucose can be controlled by pharmacologic ad-
ministration of insulin, there is no cure for type 1 diabetes
(1). T lymphocytes play key roles in autoimmune diabetes
pathogenesis in humans and rodent models. CD4+ T cells
produce cytokines such as interleukin-2 (IL-2), interferon-g
(IFN-g), and granulocyte macrophage colony-stimulating
factor (GM-CSF) as well as promote the cytotoxic activity
of CD8+ T cells, whereas T-regulatory (Treg) cells suppress
autoimmunity (2,4–6). The balance between T cells and Treg
cells with opposing functions controls the outcome of self-
reactivity (7). Many functions of T lymphocytes are controlled
by transcription factors such as nuclear factor-kB (NF-kB)
and nuclear factor of activated T cells (NFAT) (8–10). How-
ever, the speciﬁc roles of various components of these tran-
scription factors in autoimmunity are not well understood.
NF-kB is an evolutionarily conserved, dimeric transcrip-
tion factor family comprising ﬁve members (RelA, RelB,
c-Rel, p105/p50, and p100/p52) (11). Diverse extracellular
and intracellular stimuli activate NF-kB–dependent tran-
scription and expression of gene products (11), which play
a central role in regulating several autoimmune and inﬂam-
matory disorders, including autoimmune type 1 diabetes,
type 2 diabetes, obesity, lupus, arthritis, and celiac disease
(12–16). Although NF-kB function has been implicated in
autoimmunity and type 1 diabetes, a physiologically relevant
mouse model to study the roles of NF-kB subunits in auto-
immune diabetes has not yet been described.
NF-kB REL gene and c-Rel protein function is impor-
tant in several autoimmune diseases, such as arthritis,
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celiac disease, psoriasis, and autoimmune encephalomyelitis
(16). c-Rel is critical for T-helper 1 (Th1) cell differentiation
in a model of autoimmune encephalomyelitis (17), and c-Rel
deﬁciency causes resistance in an experimental model of
this disease (18). Deﬁciency of c-Rel also confers resistance
to autoimmunity resulting from mutations in Fas ligand
(19) as well as collagen-induced arthritis (20). Furthermore,
loss of c-Rel results in resistance to streptozotocin-induced
diabetes, a mouse model of autoimmune diabetes (21). On
the other hand, c-Rel is critical for the development of
FOXP3-positive Treg cells, which suppress the activity of
self-reactive T cells and autoimmunity (22,23).
The NOD mouse is a well-recognized model of human
type 1 diabetes and has provided valuable insights into the
pathogenesis and molecular mechanisms involved in auto-
immune diabetes (24). These animals spontaneously de-
velop lymphocytic inﬁltrates in pancreatic b-cells (insulitis)
as early as 4 weeks of age, which can lead to destruction
of insulin-producing b-cells and overt hyperglycemia start-
ing as early as 12 weeks of age. NOD mice develop many
aberrant immunophenotypes, such as functionally defective
T cells, impaired development of Treg cells, poor antigen-
presenting cell function, and defective cytokine production,
all of which could be associated with NF-kB c-Rel functions
(7,16). c-Rel is the major regulator of T-cell function that
mediates autoimmunity and development of Treg cells that
suppress autoimmunity. We tested the role of c-Rel in a
spontaneous model of autoimmune diabetes by its deletion
from NOD mice. Because c-Rel deﬁciency confers resistance
to autoimmunity (16,17,20,21), we hypothesized that c-Rel
deletion from NOD mice will 1) ameliorate autoimmune
complications and 2) shed light onto some critical regulatory
mechanisms associated with autoimmunity in NOD mice.
We report that the absence of c-Rel, counter to expectation,
accelerates diabetogenesis in NOD mice. We also found that
the accelerated incidence of diabetes was attributable to the
loss of Treg cell–mediated immunosuppression.
RESEARCH DESIGN AND METHODS
Western Blotting
Thymus, spleen, and lungs were isolated from C57BL/6,
B6.c-Rel2/2, NOD, and NOD.c-Rel2/2 mice at 6–8 weeks
of age. Red blood cells were lysed, and whole-cell lysates
were prepared and analyzed by Western blotting as pre-
viously described (25).
Quantitative Real-Time PCR
Cells were stimulated at various time points with plate-
bound anti-CD3 and anti-CD28 (2 mg/mL each) antibodies.
Quantitative real-time PCR using TaqMan Gene Expression
Assays (Applied Biosystems, Foster City, CA) was performed
as previously described (26). The results obtained for indi-
vidual genes were normalized to the expression of UBE2D2.
Treg Cell Supplementation
Congenic FOXP3-IRES-GFP NOD mice expressing green
ﬂuorescent protein (GFP) in their Treg cells were sacriﬁced
at 6–10 weeks of age. Spleen and lymph nodes were har-
vested, red blood cells were lysed, and GFP-positive Treg
cells were isolated by FACS using a MoFlo XDP cell sorter
with a 488-nm laser and detected using a 530/40 ﬂuores-
cein isothiocyanate ﬁlter. Cells were washed and sus-
pended at 200,000 cells in 150 mL PBS and injected
into c-Rel–deﬁcient NOD mice.
Statistical Analysis
Differences in gene expression were analyzed using two-tailed
unpaired Student t test with Prism software (GraphPad,
La Jolla, CA). Data are presented as mean 6 SEM. P , 0.05
was considered signiﬁcant unless otherwise indicated. The
percentage of diabetes in mice was statistically analyzed
by a log-rank test in Prism.
RESULTS
Expression of NF-kB Proteins in c-Rel–Deﬁcient
NOD Mice
To study the role of c-Rel in spontaneous diabetogenesis
in NOD mice, we generated c-Rel knockout mice on the
NOD background by using a marker-assisted speed congenic
approach (Fig. 1A and B) (27). We analyzed the expression of
NF-kB protein subunits by Western blotting in wild-type
and c-Rel–deﬁcient C57BL/6 mice and NOD mice to 1) con-
ﬁrm the absence of c-Rel and 2) examine whether c-Rel de-
ﬁciency affects the expression of other NF-kB subunits. We
analyzed cells from two lymphoid compartments, thymus
(Fig. 1C) and spleen (Fig. 1D), as well as a nonlymphoid
compartment, lungs (Supplementary Fig. 1A). As expected,
c-Rel was absent in c-Rel–deﬁcient mice, whereas the expres-
sion of other NF-kB subunits, p65, RelB, p105/p50, and
p100/p52, were comparable in spleen and lungs of control
and c-Rel–deﬁcient NOD mice. Analysis of thymic NF-kB
proteins showed a modest decrease in the p52 subunit levels
in c-Rel–deﬁcient NOD mice, whereas no change in the
level of its precursor, p100, was observed (Fig. 1C and
Supplementary Fig. 1B).
c-Rel Deﬁciency Does Not Affect the Development
of Major Hematopoietic Cells in NOD Mice
To examine whether c-Rel deﬁciency affects develop-
ment or survival of major cell populations of hemato-
poietic origin, we analyzed lymphoid and myeloid cells
from 6–8-week-old prediabetic, normoglycemic, NOD
c-Rel+/+, NOD c-Rel+/2, and NOD c-Rel2/2 mice. We did not
observe signiﬁcant differences in the numbers (Fig. 2A) or
proportions (Fig. 2B) of CD4+ CD8+ double-positive, CD42
CD82 double-negative, CD4+ or CD8+ single-positive, or
T-cell receptor (TCR) (gd)–positive T-cell populations in the
thymus. Furthermore, no differences were found in the
numbers (Fig. 2C) or percentages (Fig. 2D) of CD4+, CD8+
abT cells; CD19+ B cells; CD11b+ and/or CD11c+ myeloid/
dendritic cells; or gdTCR-positive T cells in the spleen.
These results show that the development of these ma-
jor hematopoietic subsets is not altered on the c-Rel–deﬁcient
NOD background.
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c-Rel Deﬁciency Selectively Decreases Treg
Cell Numbers in NOD Mice
c-Rel is crucial for the expression of Treg cell–speciﬁc tran-
scription factor FOXP3 and the development of Treg cells
in C57BL/6 mice (22,23,28). Consistent with this, the pre-
sent c-Rel–deﬁcient NOD mice showed .80% and .75%
reduction in FOXP3-positive CD4+ Treg cells in the thymus
(Fig. 3A) and spleen (Fig. 3B), respectively, with the het-
erozygote showing intermediate percentages of FOXP3-
positive cells in both cases. The differences in proportion
of FOXP3-positive cells in NODmice compared with that in
c-Rel–deﬁcient NOD mice for both thymus (Fig. 3C) and
spleen (Fig. 3D) were found to be highly signiﬁcant (P ,
0.0001). We also found that CD4+ CD25+ Treg cells isolated
from c-Rel–competent NOD and c-Rel–deﬁcient NOD mice
exhibited similar suppressive ability on the proliferation of
CD4+ T cells isolated from NOD mice (Fig. 3E and F). The
data suggest that c-Rel deﬁciency does not compromise the
suppressive function of Treg cells and that the residual
Treg cells in NOD c-Rel2/2 mice are fully functional.
c-Rel Is Required for the Expression of Selected
Cytokines and FOXP3 in T Cells of NOD Mice
c-Rel has been previously shown to be important for T-cell
function and expression of several TCR-induced genes
(16,29,30). We isolated CD4+ T cells from NOD c-Rel+/+,
NOD c-Rel+/2, and NOD c-Rel2/2 mice and studied TCR-
induced gene expression following anti-CD3/CD28 costimu-
lation. We found that T cells from NOD c-Rel2/2 mice
showed greatly decreased anti-CD3/CD28–induced expres-
sion of proautoimmune Th1 cytokines IL-2, IFN-g, and
GM-CSF (Fig. 4A). Genes such as IL-4 that are suggested
Figure 1—Generation of c-Rel–deﬁcient NOD mice. A: c-Rel knockout mice in C57BL/6 background were mated with NOD mice, and the
heterozygotes obtained were mated with NOD mice in six successive generations as indicated in the table. B: Up to 15 mice from each
generation were assessed by genome scanning to identify the percent incorporation of NOD genome. Shown is the highest percentage of
NOD genome obtained in each generation. C and D: Expression of NF-kB family members in thymus and spleen of c-Rel–deﬁcient
C57BL/6 and NOD mice. Total cell lysates of thymus (C) and spleen (D) of 6–8-week-old mice were prepared and 20–30 mg of protein
probed as indicated. Two representative samples for each strain are shown from four or more mice per strain. Normalized protein levels
were conﬁrmed by b-actin staining.
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Figure 2—Major hematopoietic cell populations in NOD mice are not affected by c-Rel deﬁciency. Flow cytometric analysis of hemato-
poietic populations in thymus (A and B) and spleen (C and D) comparing NOD c-Rel+/+, heterozygous NOD c-Rel+/2, and homozygous NOD
c-Rel2/2 mice. A: Representative plots of CD4 vs. CD8 and TCRb vs. TCRgd from three independent experiments for thymocytes.
B. Histogram summary of three experiments with percentages (mean 6 SEM) for double-negative (DN), double-positive (DP), CD4, and
CD8 single-positive subsets as well as gdT cells, showing normal distributions of thymocytes in all three mouse genotypes. C: Represen-
tative plots of CD4 vs. CD8, CD19 vs. TCRb, CD11c vs. CD11b (gated on CD192 cells), and TCRgd vs. CD3, for splenocytes. D: Histogram
summary of three experiments with percentages (mean 6 SEM) for CD19+ B cells, CD4+, CD8+, and gdT cells as well as CD11b+ myeloid
cells, showing normal distributions of cells in all three mouse genotypes. FACS plots are representative of three experiments, and bar
graphs represent the average of three mice per genotype.
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to have a c-Rel binding site in their promoter regions
(31), and IL-10, the expression of which was previously
shown to be diminished in the absence of c-Rel (32), showed
only a moderate decrease, suggesting that they only partially
depend on c-Rel for their expression (Fig. 4A). As expected,
expression of these genes in c-Rel heterozygote mice was
intermediate between c-Rel wild-type and c-Rel–deﬁcient
T cells. c-Rel deﬁciency was found to have only minimal
effects on the expression of other NF-kB–dependent genes,
such as CD25 (Fig. 4A). We also analyzed the expression of
IL-2 and IFN-g by ELISA and found that the protein levels of
both these cytokines were dramatically decreased in c-Rel–
deﬁcient C57BL/6 and NOD mice (Fig. 4B). Because the total
CD4+ T-cell pool also contains CD4+ CD25+ Treg cells, we
separated Treg cells from total CD4+ T cells and studied TCR-
induced gene expression, exclusively in CD4+ CD252 T cells.
We found that removal of Treg cells showed some differences,
such as decreased early induction of IL-2, decreased sustained
IL-4 production, and decreased basal level of CD25 in CD4+
CD252 T cells compared with that in total CD4+ T cells
(Supplementary Fig. 2A).
Consistent with the decreased FOXP3 expression ob-
served by intracellular staining (Fig. 3A and B), mRNA
expression of FOXP3 was also greatly decreased in c-Rel–
deﬁcient CD4+ T cells (Fig. 4C). As previously shown, the
function of c-Rel is critical for both IL-2 and FOXP3 ex-
pression (16). IL-2 has also been suggested to be required
for the expression of FOXP3 as well as the development
and survival of Treg cells (9,28,33). Therefore, we asked
whether the decreased FOXP3 expression and Treg cell
numbers in c-Rel–deﬁcient mice result from decreased
IL-2 production. We examined the TCR-induced FOXP3
expression in CD4+ T cells isolated from wild-type and
c-Rel knockout C57BL/6 mice (Supplementary Fig. 2B)
Figure 3—A and B: FOXP3 cells are differentially affected by the loss of one or two copies of c-Rel on the NOD background. Represen-
tative plots of surface CD4 vs. intracellular FOXP3 for thymocytes (A) and splenocytes (B). C and D: Histogram summary of four exper-
iments showing the percentage of FOXP3+ CD4+ cells (mean 6 SEM) in thymus (C) and the percentage of FOXP3+ cells among CD4+ cells
in spleen (D) for each genotype. Results from t tests comparing each pair of genotypes for four mice from each group are as shown. E and
F: c-Rel–deﬁcient Treg cells are functionally competent in suppressing CD4+ T-cell proliferation in vitro. E: Flow cytometric analysis of
carboxyﬂuorescein succinimidyl ester (CFSE) dilution in CD4+ T cells alone, with NOD Treg cells, and with NOD c-Rel2/2 Treg cells.
Histograms are representative of three mice per genotype from three experiments (F ). Percentage of proliferating CD4+ T cells based on
CFSE assay data. Bar graphs represent mean of duplicates from three mice per group. *P < 0.05, **P < 0.005, ***P < 0.0001.
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Figure 4—c-Rel deﬁciency decreases cytokine and FOXP3 expression in NOD mice. A: CD4+ T cells were puriﬁed from c-Rel+/+, c-Rel+/2
and c-Rel2/2 NOD mice by magnetic-activated cell sorting. Cells were stimulated with plate-bound anti-CD3 and anti-CD28 antibodies
(2 mg/mL each) for the indicated time points. Gene expression was analyzed by real-time PCR from at least three mice per genotype in
triplicate. B: Analysis of the expression of IL-2 and IFN-g in culture supernatant by ELISA. CD4+ T cells from C57BL/6 and NOD mice were
treated as in A for 18 h. Data are the mean of triplicates from three mice per group. C: Expression of FOXP3 was analyzed as in A in triplicate
from three mice per group. D: CD4+ T cells were treated as in A, and the effect of exogenous IL-2 (50 units/mL) on FOXP3 expression was
analyzed. Data are the mean of triplicates from three mice per genotype. E: CD8+ T cells were puriﬁed from c-Rel+/+ and c-Rel2/2 NOD mice by
magnetic-activated cell sorting. Cells were stimulated and gene expression analyzed by real-time PCR as in A from at least three mice in
triplicate. Expression of indicated genes was normalized to UBE2D2. Data are mean 6 SEM. Unpaired Student t test comparing gene
expression in c-Rel+/+ and c-Rel2/2 T cells. *P < 0.05, **P < 0.01, ***P < 0.001. IFNG, interferon-g; ns, nonsigniﬁcant; WT, wild type.
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and parental NOD and c-Rel–deﬁcient NOD mice (Fig. 4D)
in the presence of exogenous IL-2. The addition of IL-2 did
not increase the FOXP3 transcription in CD4+ T cells iso-
lated from either strain, suggesting that the defect is
indeed due to the absence of c-Rel and not due to the
insufﬁciency of IL-2. Consistent with this, c-Rel has been
shown to induce FOXP3 transcription directly by binding
to the enhancer region of FOXP3 gene (22).
Because CD8+ T cells are the major cytotoxic force
behind diabetogenic b-cell destruction, we also performed
anti-CD3/CD28–induced gene expression studies by using
CD8+ T cells. Similar to CD4+ T cells, c-Rel deﬁciency also
compromised TCR-induced expression of IL-2, IFN-g, and
GM-CSF in CD8+ T cells (Fig. 4E, top panels). TCR-induced
IL-4 and CD25 expression in CD8+ T cells did not show
signiﬁcant dependence on c-Rel. IL-10 was not induced by
TCR activation in either NOD or NOD c-Rel2/2 CD8
T cells, and its expression showed a decrease from basal
levels after TCR activation (Fig. 4E, bottom panels).
c-Rel Deﬁciency Exacerbates Autoimmunity
in NOD Mice
Overt hyperglycemia in NOD mice is preceded by in-
ﬁltration of immune cells in the pancreas (insulitis) that
mediates autoimmune destruction of the islets. We ana-
lyzed the pancreas of control and c-Rel–deﬁcient pre-
diabetic NOD mice of 8–9 weeks of age with a blood
glucose level in the range of 80–120 mg/dL by hematox-
ylin and eosin staining. We found that the absence of
c-Rel led to a dramatic increase in insulitis, suggesting a
critical role of c-Rel in suppressing autoimmunity (Fig. 5A,
percentages of insulitis score under respective images).
The islets from c-Rel–deﬁcient NOD pancreas were strongly
stained with an anti-CD3 antibody, conﬁrming that the
inﬁltrating cells are predominantly T cells (Fig. 5B). We
performed the scoring of insulitis as previously described
(34), and the average insulitis score (Fig. 5C) and the
percentage of islets showing inﬁltration (Fig. 5D) were
calculated. Because c-Rel deﬁciency enhanced the T-cell
inﬁltration in the islets, we studied whether these cells
are hyperresponsive to T-cell activation. We found that
CD4+ T cells from the spleens of c-Rel2/2 NOD mice
showed signiﬁcantly decreased proliferative response
in vitro compared with NOD mice after TCR costimula-
tion (Fig. 5E).
We then followed the development of diabetes in c-Rel2/2
NOD mice compared with the c-Rel+/2 heterozygote and
c-Rel+/+ NOD mice. Consistent with the increase in prediabe-
tes insulitis, we found that diabetogenesis was also accelera-
ted in c-Rel–deﬁcient NOD mice. Unlike the NOD female
mice, which showed ;80% diabetes occurrence by 25 weeks
of age, 100% of c-Rel–deﬁcient and 80% of the c-Rel+/2 NOD
female mice were diabetic by 17 weeks of age (Fig. 5F).
c-Rel Deﬁciency Increases CD4+ T-Cell Proliferation in
the Pancreas
To further understand the mechanistic basis of accelerated
diabetes development in NOD c-Rel2/2 mice, we examined
the extent of immune cell inﬁltration and proliferation of
T cells among total cells in the pancreas and pancreatic
lymph nodes of NOD and NOD c-Rel2/2 mice. We found
that the percentages of CD4+ and CD8+ T cells were signif-
icantly increased by 2.5- and 2.0-fold, whereas the percent-
age of Treg cells was found to be decreased by 75% in the
pancreas of NOD c-Rel2/2 mice (Fig. 6A, top panels). Their
percentages of B cells, natural killer (NK) cells, and macro-
phages showed only a modest increase and were statisti-
cally not signiﬁcant (Fig. 6A, bottom panels). Thus, similar
to the increased insulitis and T-cell inﬁltration observed in
histological analyses in 8–9-week-old mice (Fig. 5A and B),
ﬂow cytometry analyses using 6–8-week-old mice showed a
trend of increased inﬁltration of T cells in the pancreas
(Fig. 6A). We also examined the pancreatic lymph nodes
of NOD and NOD c-Rel2/2 mice and found no signiﬁcant
differences in the percentages of CD4+ and CD8+ T cells,
B cells, NK cells, or macrophages, whereas the number of
Treg cells was decreased by 70% (Fig. 6B). Next, we studied
the proliferation of CD4+ and CD8+ T cells by Ki67 staining
and found that the percentage of proliferating CD4+ T cells
was signiﬁcantly higher in the pancreas but not in the
pancreatic lymph nodes (Fig. 6C, top panels). We also
found an increase in proliferating CD8+ T cells but to a
lesser extent than that of CD4+ T cells (Fig. 6C, bottom
panels). Although the TCR-induced in vitro proliferative
capacity of c-Rel–deﬁcient CD4+ T cells was reduced (Fig.
5E), the in vivo proliferation within the pancreas was
signiﬁcantly increased, suggesting that the paucity of
Treg cells in both pancreas and pancreatic lymph nodes
allows enhanced proliferation of CD4+ T cells in the
pancreas.
Supplementation of c-Rel–Competent Treg Cells
Reverts the Accelerated Diabetes in c-Rel–Deﬁcient
NOD Mice
Because the paucity of Treg cells in pancreas and pancreatic
lymph nodes (Fig. 6A and B) might prove to be the un-
derlying reason for the enhanced CD4+ T-cell proliferation
and accelerated diabetogenesis in NOD c-Rel2/2 mice, our
next aim was to address whether supplementation with
c-Rel–competent Treg cells could reverse their aggravated
autoimmunity. To accomplish this, we used congenic
FOXP3-IRES-GFP NOD mice that express GFP in Treg cells.
Analysis of spleen (Supplementary Fig. 3A) and lymph
nodes (Supplementary Fig. 3B) from these mice showed
2.1% and 5.6% of GFP-positive Treg cells, respectively.
We isolated these GFP-positive Treg cells by FACS and
retro-orbitally injected 6–8-week-old NOD c-Rel2/2 mice
with 2 3 105 GFP-positive cells/mouse in PBS. We found
that supplemented GFP-positive Treg cells were present in
the pancreata (Fig. 7A, left) and pancreatic lymph nodes
(Fig. 7A, right) in NOD c-Rel2/2 mice 5 weeks postrecon-
stitution. We scored the pancreata for insulitis (Fig. 5C and
D) and calculated the average insulitis score (Fig. 7B) and
the percentage of islets showing inﬁltration (Fig. 7C). We
found that supplemented Treg cells reversed the severity of
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insulitis in NOD c-Rel2/2 mice. Next, we reconstituted
12 NOD c-Rel2/2 recipient mice and conﬁrmed the pres-
ence of circulating GFP-positive Treg cells in their blood
(Fig. 7D). While all the c-Rel–deﬁcient NOD mice showed
hyperglycemia by 18 weeks of age, only 50% of animals
supplemented with the GFP-positive Treg cells developed
hyperglycemia at this stage. We continued to collect the
data to 35 weeks and found that Treg cell supplementation
Figure 5—c-Rel deﬁciency accelerates insulitis and diabetes in NOD mice. A: Pancreata were isolated from 8–9-week-old prediabetic
female NOD c-Rel+/+ (top) and c-Rel2/2 (bottom) mice and analyzed by hematoxylin and eosin staining for insulitis. The histology shows
islets representing insulitis scores of 0–3 and their percentage of incidence from NOD and NOD c-Rel2/2 mice from >10 animals analyzed
per group. B: T-cell inﬁltrates in the islets. Pancreas sections of NOD c-Rel2/2 mice were stained using an anti-CD3 or isotype control
antibodies. Scale bar = 100 mm. Data represent staining performed on pancreatic tissue sections from four mice for each genotype. C and
D: Insulitis score and the percentage of islets with each grade of insulitis in NOD and c-Rel2/2 NOD mice. C: Insulitis was scored from
seven mice per genotype, and the mean score of individual mice was plotted. Scale: no inﬁltration = 0; peri-islet inﬁltration of <25% of
islet = 1; invasive inﬁltration of 25–50% of the islet = 2; high inﬁltration of >50% of the islet = 3. The insulitis score was analyzed using
ANOVA; P < 0.0001 (Prism). D: Percentage of islets with each grade of insulitis calculated from 63 c-Rel+/+ and 59 c-Rel2/2 islets from
36 independent sections for each mouse, with a total of seven mice per group. E: TCR-induced proliferation of CD4+ T cells isolated from
spleen of NOD and c-Rel2/2 NOD mice. Data are mean of triplicates from two mice per genotype. *P < 0.05. F: c-Rel+/+ (n = 26), c-Rel+/2
(n = 16), and c-Rel2/2 (n = 27) NOD mice were analyzed weekly for blood glucose levels. Once the glucose level reached 250 mg/dL, the
mice were monitored twice a week. Mice showing three consecutive readings of 250 mg/dL were marked as diabetic. Signiﬁcant differ-
ences by log-rank test were seen between c-Rel+/+ and c-Rel2/2 mice (***P < 0.001) and c-Rel+/+ and c-Rel+/2 mice (*P < 0.05).
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Figure 6—A and B: c-Rel deﬁciency signiﬁcantly increases the number of CD4+ and CD8+ T cells and decreases Treg cells in the pancreas.
Pancreata (A) and pancreatic lymph nodes (PLNs) (B) were isolated from 6–8-week-old prediabetic female NOD and NOD c-Rel2/2 mice.
Single-cell suspensions were analyzed by ﬂow cytometry for CD4+ and CD8+ T cells, FOXP3+ Treg cells, B cells, NK cells, and macro-
phages. For the entire staining, single-cell isolates from pancreas and PLNs were prepared as described in the Supplementary Data. Live
cells were gated ﬁrst, and percentage of cell populations of interest among the total cells in the pancreas and PLNs were determined. C:
c-Rel deﬁciency increases proliferation of CD4+ T cells in the pancreas as assessed by the costaining of surface CD4 and intracellular
staining of the proliferation marker Ki67. Data are mean 6 SEM of seven mice for pancreas and ﬁve mice for PLN per group. *P < 0.05,
**P < 0.01, ***P < 0.001. ns, nonsigniﬁcant.
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reversed the enhanced pathology of diabetes caused by c-Rel
deﬁciency, although it did not protect the mice from devel-
oping diabetes (Fig. 7E).
DISCUSSION
Autoimmunity results from a combined action of genetic,
environmental, and immunological factors that lead to
impaired central and/or peripheral immune tolerance.
The etiology of type 1 diabetes is also associated with
a shortfall of immune tolerance in which the immune
system recognizes pancreatic islet cells as foreign and
destroys them (35). However, the root cause that ignites
the autoimmune response in diabetes remains enigmatic
(1). NF-kB family members play substantial roles in reg-
ulating multiple aspects of immune responses and auto-
immunity. Deﬁciency of RelB and NF-kB2 (p100/p52)
Figure 7—Supplementation of c-Rel–competent Treg cells reverts exacerbated diabetes in c-Rel2/2 NOD mice. A: Presence of trans-
planted Treg cells in pancreas (left) and pancreatic lymph node (right). FACS plot represents the ﬂow cytometry performed using the organs
from three mice each per group, 5 weeks postsupplementation of GFP-positive Treg cells. B: Insulitis scores at 5 weeks postsupplemen-
tation of GFP-positive Treg cells from four individual mice per group and the mean score 6 SEM are plotted. C: Percentage of islets with
each grade of insulitis calculated from 38 c-Rel2/2 and 35 GFP-positive Treg-supplemented c-Rel2/2 islets from 15 independent sections
for each mouse from four mice per group (P < 0.001). D: Presence of transplanted Treg cells examined by tail vein bleeding and ﬂow
cytometry for GFP-positive cells in blood 10 weeks postsupplementation in 11 NOD and 12 NOD c-Rel2/2 mice. E: c-Rel+/+ (n = 11),
c-Rel2/2 (n = 12), and c-Rel2/2 + GFP-positive Treg (n = 12) NOD mice were analyzed for blood glucose levels as described in Fig. 5F.
Signiﬁcant differences by log-rank test were seen between c-Rel+/+ and c-Rel2/2 mice (***P < 0.001) as well as between c-Rel+/+ and
c-Rel2/2 + GFP-positive Treg reconstituted mice (***P < 0.001). SSC-A, side-scatter area.
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results in enhanced autoimmunity (36,37), whereas the
absence of c-Rel has been suggested to confer resistance
to autoimmunity (16,17). Several abnormal immunophe-
notypes of NOD mice, such as autoreactivity of T cells,
autoantibody production by B cells, defective antigen pre-
sentation, and abnormal proautoimmune and inﬂam-
matory cytokine production, could be associated with
deregulated c-Rel function. c-Rel is critical for the func-
tion of Th1 cells, including induction of genes such as
IL-2, IFN-g and GM-CSF (29,30). c-Rel is also required for
the induction of FOXP3 and the development of Treg cells
(22,28). These Th1 and Treg cell functions play major and
possibly opposing roles in autoimmune diabetes. In this
study, we developed the novel c-Rel–deﬁcient NOD mouse,
which is a natural system to study how total loss of c-Rel
affects diabetogenesis. Because c-Rel knockout mice are re-
sistant to autoimmunity in general (16), we speculated that
c-Rel deﬁciency might delay or prevent the autoimmune
diabetogenesis in NOD mice. However, against expectation,
the results show that the absence of c-Rel on the autoim-
mune NOD background did not prevent or delay autoim-
munity. Rather, it resulted in an acceleration of insulitis and
frequency of occurrence of type 1 diabetes associated with a
paucity of immunosuppressive FOXP3-positive Treg cells.
c-Rel is a critical component of the IL-2 promoter–
activating complex (38). However, IL-2 is induced by mul-
tiple pathways in T cells (39), and a minimal amount of
IL-2 is produced even in the absence of c-Rel (30) (Fig.
4A). IL-2 has been implicated as a critical factor in auto-
immunity (40), including type 1 diabetes in humans and
NOD mice, playing complex roles in the balance between
diabetes pathogenesis and protection by Treg cells (41),
with Treg cells being particularly sensitive to reductions in
IL-2 levels (42,43). However, the addition of exogenous
IL-2 did not increase TCR-induced FOXP3 expression in
c-Rel–deﬁcient T cells, suggesting the requirement of c-Rel
in transcriptional regulation of FOXP3.
Acceleration of disease despite a decrease in IL-2,
IFN-g, and GM-CSF production, both by CD4+ and CD8+
T cells, emphasizes the critical importance of Treg cells in
suppressing autoimmunity in NOD mice. In agreement
with this, Treg cells have been previously shown to play
a critical role in suppressing the onset of autoimmune
diabetes in NOD mice (44,45). Furthermore, restoration
of diabetes progression in c-Rel–deﬁcient NOD mice to a
level similar to that in NOD mice after injection of c-Rel–
competent NOD Treg cells shows that the absence of Treg
cells are indeed responsible for the observed accelera-
tion of disease.
Of note, in the current reconstitution studies with
FOXP3-positive cells (Fig. 7), although the c-Rel–deﬁcient
NOD mice recovered from accelerated diabetes develop-
ment, Treg cell supplementation was not sufﬁcient to de-
crease diabetes beyond that seen in the c-Rel–competent
NOD mice. Although it is possible that the number of
Treg cells we injected was not sufﬁcient to fully suppress
the autoimmune response, restoration of normal disease
kinetics is not necessarily surprising because wild-type
NOD Treg cells are normally unable to prevent the devel-
opment of type 1 diabetes in NOD mice. In addition, Treg
cells appear to be less effective at regulating pathogenic
T cells in later stages (46–48). Restoration of wild-type
NOD disease progression with the injection of labeled
wild-type NOD Treg cells also suggests that either the
observed decrease in cytokine production and prolifera-
tion by c-Rel–deﬁcient T cells observed in vitro has no
effect on disease progression or alternative mechanisms
that promote the disease are present within the T cells or
other cells present in the NOD mice. In line with this
possibility, the data show that T cells in the pancreas
have enhanced proliferative capacity. The paucity of
Treg cells in both pancreas and pancreatic lymph nodes
may account for diminished suppression of autoreactive
T cells in these compartments and enhanced proliferation
of CD4+ and CD8+ T cells in the pancreas.
Because c-Rel is present in all hematopoietic cells and
in pancreatic b-cells (16,23), altered NF-kB functions in
those cells may play additional roles. The current detailed
analysis of immune cells in pancreas and pancreatic lymph
nodes suggests that c-Rel deﬁciency has only a modest
effect on inﬁltration of B cells, NK cells, and macrophages
into the pancreas. However, the overall modest increase
in inﬁltrating immune cells suggests increased trafﬁcking
of immune cells into the pancreas of NOD c-Rel2/2 mice.
c-Rel and NF-kB, in general, play an antiapoptotic role in
several cell types, including pancreatic b-cells (13,49). The
absence of c-Rel may render b-cells of NOD mice prone to
apoptosis by compromising expression of antiapoptotic
molecules, such as Bcl-XL, Bcl-2, and A1 (16), which
may contribute to the high incidence of diabetes in
c-Rel2/2 NOD mice. Concurring with this possibility, in-
hibition of NF-kB in pancreatic b-cells of NOD mice has
been shown to accelerate autoimmune diabetes (50). We
examined the serum insulin levels in prediabetic NOD and
NOD c-Rel2/2 mice to conﬁrm that their b-cell function
is intact. We found no signiﬁcant difference in insulin
secretion (Supplementary Fig. 3B), which suggests that
c-Rel deﬁciency does not cause inherent defects in b-cells.
Moreover, in our experiments, supplementation of Treg cells
rescues the NOD c-Rel2/2 animals from accelerated devel-
opment of diabetes, and the blood glucose level becomes
comparable to that in NOD mice, further suggesting that
b-cells in c-Rel–deﬁcient NOD mice do not have intrinsic
defects that lead to their death and they behave similarly to
those in NOD mice.
In a previous study of c-Rel and NF-kB1 (p105) knock-
out mice on the C57BL/6 background, these NF-kB sub-
units were suggested to play a role in susceptibility to
diabetes (21). Both these knockout mice showed reduced
levels of inﬂammatory cytokines and some degree of re-
sistance to diabetes development after injection with the
chemical streptozotocin. In contrast, c-Rel–deﬁcient NOD
mice, which may be a better model of the human disease,
showed accelerated diabetes development, suggesting a
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difference in NF-kB c-Rel involvement in chemical-induced
and spontaneous diabetogenesis.
In humans, the incidence of autoimmune diabetes is
constantly rising, and the secondary complications of
hyperglycemia are increasing. Because of its polygenic and
varied nature, knowledge of the molecular mechanisms
involved in the complications of type 1 diabetes is limited.
We showed previously that hyperglycemia-induced
O-GlcNAcylation activates c-Rel–dependent transcription.
This results in enhanced production of Th1 cytokines that
may culminate in exacerbation of autoimmunity in diabe-
tes (26). The current novel c-Rel–deﬁcient NOD mouse
model can be used to 1) dissect the roles of c-Rel in
various components of type 1 diabetes pathogenesis in
the NOD mouse in both the prediabetic and the hyper-
glycemic state and 2) generate transgenic mice expressing
non–O-GlcNAcylatable or other mutants of c-Rel to study
the role of posttranslational modiﬁcations regulating c-Rel
function in autoimmune diabetes. This is especially impor-
tant because the current results suggest that inhibition of
global c-Rel function may not prove to be a desirable strat-
egy to treat autoimmune diabetes.
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